Ziel
Infections caused by antimicrobial-resistant bacteria (AMRB) account for an increasing proportion of healthcare-associated infections, particularly in high-risk units such as intensive care units and surgery; patients discharged to rehabilitation units often remain carriers of AMRB, contributing to their dissemination into longer-term care areas and within the community.
The overall objective of MOSAR is to gain breakthrough knowledge in the dynamics of transmission of AMRB, and address highly controversial issues by testing strategies to combat the emergence and spread of antimicrobial resistance, focusing on the major and emerging multi-drug antimicrobial resistant microorganisms in hospitals, now spreading into the community. Microbial genomics and human response to carriage of AMRB will be integrated with health sciences research, including interventional controlled studies in diverse hospital settings, mathematical modelling of resistance dynamics, and health economics.
Wissenschaftliches Gebiet
- medical and health sciencesclinical medicinephysiotherapy
- medical and health scienceshealth sciences
- medical and health sciencesclinical medicinecritical care medicine
- social scienceseconomics and businesseconomicshealth economics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Programm/Programme
Aufforderung zur Vorschlagseinreichung
FP6-2005-LIFESCIHEALTH-6
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
IP - Integrated ProjectKoordinator
PARIS
Frankreich
Auf der Karte ansehen
Beteiligte (16)
85500 UTRECHT
Auf der Karte ansehen
TEL AVIV
Auf der Karte ansehen
LONDON
Auf der Karte ansehen
CRETEIL
Auf der Karte ansehen
105 LE CHESNAY
Auf der Karte ansehen
CHILLY MAZARIN
Auf der Karte ansehen
CARDIFF
Auf der Karte ansehen
HAMBURG
Auf der Karte ansehen